Patrick Finn, Ph.D., serves as the President and Chief Operating Officer at Twist Bioscience Corp, a leading synthetic biology and genomics company. Dr. Finn joined Twist Bioscience in 2014 and has been instrumental in guiding the company's growth and development. With over two decades of experience in the life sciences industry, he has a strong background in biotechnology, molecular biology, and product development. Prior to Twist Bioscience, Dr. Finn held various leadership positions at companies such as Life Technologies, where he served as Vice President of Genetic Analysis, and Affymetrix, where he was Senior Director of Research and Development. Under Dr. Finn's leadership, Twist Bioscience has made significant strides in advancing synthetic biology and genomics technologies. He has played a key role in the development and commercialization of the company's proprietary silicon-based DNA synthesis platform, which enables the rapid and cost-effective production of high-quality synthetic DNA. This technology has far-reaching applications in areas such as drug discovery, agriculture, and data storage. Dr. Finn's strategic vision and operational expertise have been crucial in expanding Twist Bioscience's product offerings and establishing partnerships with leading research institutions and biopharmaceutical companies. As President and COO, Dr. Finn oversees Twist Bioscience's day-to-day operations, including research and development, manufacturing, and commercial activities. He works closely with the executive team to set the company's strategic direction and drive growth initiatives. Dr. Finn's leadership has been recognized by the industry, and he has been invited to speak at numerous conferences and events on topics related to synthetic biology, genomics, and the future of biotechnology. With his extensive experience and dedication to innovation, Dr. Finn continues to play a vital role in positioning Twist Bioscience as a leader in the rapidly evolving field of synthetic biology.